In an interactive session hosted by GRAIL at Becker's 11th Annual CEO + CFO Roundtable, Roni Christopher, DHSc, senior director of care delivery at GRAIL, and Adam Whitten, vice president of operations at Mercy (St. Louis), discussed how multi-cancer early detection testing can support health systems and patient outcomes.

Biotech company Orbis Health Solutions was approved to begin a phase 3 clinical trial of its melanoma vaccine, ABC News reported Jan. 20.

This is the first year since the COVID-19 pandemic began that hospitals must independently decide if and how to implement masking, and cancer centers across the country are taking different approaches.

Los Angeles-based UCLA Health appointed Mediget Teshome, MD, chief of breast surgery and director of breast health.

The FDA recently approved the nation's first artificial intelligence-powered medical device that detects skin cancer. 

Drugmakers have their sights set on a class of cancer drugs known as antibody drug conjugates, or ADCs, to drive growth, CNBC reported Jan. 14. 

The expected increase in new cancer diagnoses this year is record-setting, even as overall cancer mortality is expected to continue its decline, the American Cancer Society said in its latest report.

Substance use disorders are highly variable among cancer patient populations, and new research points to five cancers with the highest prevalence of SUDs, according to a study published Jan. 11 in JAMA. 

A combination of artificial intelligence and image screening software used by a blogger allegedly found evidence of data manipulation across a range of research papers published by four experts at the Dana-Farber Cancer Institute in Boston dating back to 1997.

West Orange, N.J.-based RWJBarnabas Health has three new cancer centers under construction, including New Jersey's first freestanding cancer center.

Cancer diagnosis rates among people under 50 are on the rise. In the U.S, the rate among this group jumped nearly 13% from 2000 — when it was 95.6 cases per 100,000 people — to 107.8 by 2019. Physicians and scientists are baffled, scrambling to determine what's beneath the surge and how to identify people at high risk, The Wall Street Journal reported Jan. 11.

An American Cancer Society study found states with expanded Medicaid status had more insurance coverage for newly diagnosed cancer patients and fewer uninsured patients.

City of Hope and Children's Oncology Group researchers conducted the largest clinical trial to date to investigate the prevention of childhood cancer survivors from developing heart failure.

Four groups are asking policymakers to address the "urgent threat facing cancer treatment access" by changing Medicare payments.

Jacksonville, Fla.-based Nemours Children's Health researchers found the Zika virus could be used to shrink neuroblastoma tumors.

Boston-based Dana-Farber Cancer Institute recently made its first official pitch to Massachusetts regulators about its $1.68 billion proposal to establish a standalone cancer hospital in partnership with Beth Israel Deaconess Medical Center, The Boston Globe reported Jan. 8. 

Charleston, S.C.-based MUSC Hollings Cancer Center has named William Hawkins, MD, as its inaugural deputy director, according to a Jan. 3 news release.

Mayo Clinic is launching a $9 million expansion and renovation to its New Prague cancer center beginning in 2024.

Most private and federal health insurance programs require prior authorization for certain treatments in order to reduce spending and avoid unnecessary care; however, the process may increasingly prevent patients from receiving the right care when they need it, The Lund Report reported Jan. 2.

Seattle-based Fred Hutchinson Cancer Center is facing nine lawsuits after a cyberattack leaked clinical data in November.